Taiwan FDA registration f88325cca0e4fd61f62b7704eb5f73cb
Xiec anti-cyclic citrullinated IgG antibody reagent
TW: 協克抗環瓜氨酸IgG抗體試劑
Taiwan·Risk Class 2·EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG·Registered Mar 14, 2012 – Mar 14, 2022CancelledRegistration details
- Analysis ID
- f88325cca0e4fd61f62b7704eb5f73cb
- Customs Code
- DHA00602335103
Company information
- Manufacturer
- EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
- Manufacturer Country
- Germany
- Authorized Representative
- SEEKERS BIOMEDICAL CO., LTD.
Product details
- Intended Use
- This ELISA test group provides half quantitative or quantitative in vitro assays to determine human autoantibodies to IgG against cyclic citrullinated peptide (CCP).
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5775 類風濕性因子免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Mar 14, 2012
- Expiry Date
- Mar 14, 2022
- Cancellation Date
- Apr 12, 2024
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Xiec anti-cyclic citrullinated IgG antibody reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f88325cca0e4fd61f62b7704eb5f73cb and manufactured by EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG. The authorized representative in Taiwan is SEEKERS BIOMEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices